title: Monitoring for potential adverse drug reactions in patients receiving chemotherapy.
authors.affiliation: Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Ikesue
authors.forename: Mawako
authors.initials: M
authors.lastname: Ishida
authors.forename: Mayako
authors.initials: M
authors.lastname: Uchida
authors.forename: Michiko
authors.initials: M
authors.lastname: Harada
authors.forename: Tomoko
authors.initials: T
authors.lastname: Haro
authors.forename: Kazuto
authors.initials: K
authors.lastname: Mishima
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Itoh
authors.forename: Kazuya
authors.initials: K
authors.lastname: Kotsubo
authors.forename: Manabu
authors.initials: M
authors.lastname: Yoshikawa
authors.forename: Ryozo
authors.initials: R
authors.lastname: Oishi
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects; D010593:Pharmaceutical Services; D014481:United States
chemical_list: D016190:Carboplatin; D017239:Paclitaxel